Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
898.00    2.00 (0.22%)
Bid:
904.00
Ask:
906.00
Spread: 2.00 (0.221%)
Market Cap: £129.20b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Pre Stabilisation Notice

6 Feb 2019 08:40

RNS Number : 2323P
HSBC Bank plc
06 February 2019
 

6th Feb 2019

 

Banco Santander, S.A. (the "Bank")

Stabilisation Notice

 

HSBC (contact: 'Syndicate desk'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Banco Santander, S.A. (the "Bank")

Guarantor (if any):

Aggregate nominal amount:

Bmk

Description:

USD Perp NC5 AT1

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

CACIB/Credit Suisse/ Deutsche Bank /HSBC/Santander

Stabilisation period expected to start on:

6th Feb 2018

Stabilisation period expected to end no later than:

6th March 2018

Existence, maximum size & conditions of use of over-allotment facility:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEUGUAWPUPBURQ
Date   Source Headline
16th Jan 20258:22 amRNSInvitation to purchase certain instruments
15th Jan 20258:29 amRNSOffers to purchase outstanding instruments
7th Jan 20257:44 amRNSOffers to purchase outstanding instruments
31st Dec 202411:16 amRNSTotal Voting Rights
23rd Dec 202412:49 pmRNSFurther re capital reduction
20th Dec 20247:00 amRNSAgreement for the sale of stake in CACEIS
18th Dec 202412:02 pmRNSTotal Voting Rights
11th Dec 20245:46 pmRNSDirector/PDMR Shareholding
11th Dec 202412:00 pmRNSSREP Capital Requirements 2025
4th Dec 20244:16 pmRNSCapital reduction following completion of program
29th Nov 202412:13 pmRNSTotal Voting Rights
28th Nov 202411:08 amRNSBuyback programme: transactions 21-27 Nov
21st Nov 202410:54 amRNSBuyback programme: transactions 14-20 Nov
19th Nov 20245:52 pmRNSDirector/PDMR Shareholding
14th Nov 202411:08 amRNSBuyback programme: transactions 7-13 Nov
11th Nov 20246:29 pmRNSDirector/PDMR Shareholding
7th Nov 202411:10 amRNSBuyback programme: transactions 31Oct-6Nov
6th Nov 20242:34 pmRNSForm 8.3 - Smith (DS) PLC
31st Oct 20242:47 pmRNSTotal Voting Rights
31st Oct 202410:02 amRNSBuyback programme: transactions 24-30 Oct
29th Oct 20247:00 amRNSThird Quarter 2024 Results - Press release
29th Oct 20247:00 amRNS3Q 2024 Financial report & Earnings presentation
24th Oct 202411:14 amRNSBuyback programme: transactions 17-23 Oct
22nd Oct 202411:11 amRNSNotice of Third Quarter 2024 Results
17th Oct 202411:09 amRNSBuyback programme: transactions 10-16 Oct
16th Oct 20247:06 amRNSOptional early redemption ISIN ES0213900220
10th Oct 202411:08 amRNSBuyback programme: transactions 3-9 Oct
9th Oct 20247:08 amRNSEarly redemption ISIN ES0413900632
3rd Oct 202411:12 amRNSBuyback programme: transactions 26Sep-2Oct
30th Sep 20242:10 pmRNSTotal Voting Rights
30th Sep 20241:40 pmRNSInvitation to purchase certain instruments
26th Sep 202411:05 amRNSBuyback programme: transactions 19-25 Sep
24th Sep 20242:16 pmRNSDividend approval
23rd Sep 20247:33 amRNSInvitation to purchase certain instruments
19th Sep 202411:11 amRNSBuyback programme: transactions 12-18 Sep
12th Sep 202411:08 amRNSBuyback programme: transactions 5-11 Sep
11th Sep 20247:00 amRNSPricing of an accelerated placement of shares
5th Sep 202411:08 amRNSBuyback programme: transactions 27Aug-4Sep
3rd Sep 20245:06 pmRNSEarly redemption ISIN ES0213770011
30th Aug 20242:53 pmRNSTotal Voting Rights
27th Aug 20247:07 amRNSCommencement of a program to repurchase own shares
21st Aug 20249:12 amRNSForm 8.3 - Redrow plc
31st Jul 20245:32 pmRNSTotal Voting Rights
30th Jul 20247:00 amRNSAT1s Contingent Convertible securities
29th Jul 20241:26 pmRNSForm 8.3 - Darktrace PLC
26th Jul 202411:41 amRNSHalf-year Report
24th Jul 20247:00 amRNS1st Half 24 results report & earnings presentation
24th Jul 20247:00 amRNSFirst Half 2024 Results - Press release
17th Jul 202411:06 amRNSNotice of First Half 2024 Results
2nd Jul 202411:13 amRNSFurther re capital reduction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.